HRT FINANCIAL LP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1475597 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$22,504,805

-$33,075,022 QoQ

Shares Held

36,092

-63.5% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#203

of 1,322 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $848,596,144 across 183 Biotechnology names. REGN ranks #11 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,504,805	36,092	-63.5%	Shares	Defined	2026-08-14
2025-09-30	$55,579,827	98,849	+379.3%	Shares	Defined	2025-11-14
2025-06-30	$10,827,600	20,624	-12.2%	Shares	Defined	2025-08-14
2025-03-31	$14,903,770	23,499	+175.4%	Shares	Defined	2025-05-15
2024-12-31	$6,077,599	8,532	+122.4%	Shares	Defined	2025-02-14
2024-09-30	$4,032,556	3,836	-65.3%	Shares	Defined	2024-11-12
2024-03-31	$10,643,214	11,058	+82.3%	Shares	Defined	2024-05-13
2023-12-31	$5,327,707	6,066	-43.1%	Shares	Defined	2024-02-09
2023-09-30	$8,769,461	10,656	-73.8%	Shares	Defined	2023-11-13
2022-12-31	$29,327,125	40,648	+127.8%	Shares	Defined	2023-02-10
2021-09-30	$10,800,647	17,847	+27.9%	Shares	Defined	2021-11-15
2021-06-30	$7,792,191	13,951	-11.2%	Shares	Defined	2021-08-16
2021-03-31	$7,431,609	15,707	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.